Upgrade to SI Premium - Free Trial

Goldman Sachs Reiterates Sell Rating on 2Seventy Bio Inc. (TSVT)

November 12, 2024 12:52 PM
Goldman Sachs analyst Salveen Richter reiterated a Sell rating and $2.00 price target on 2Seventy Bio Inc. (NASDAQ: TSVT).The analyst ...

(Premium-only article. Please sign in or upgrade to SI Premium to view.)

Categories

Analyst Comments

Next Articles